Dabrafenib/Nivolumab/Trametinib
Fields of Study & Subjects
Melanoma and MAPK Pathways
Cancer Immunotherapy and Biomarkers
Pharmacovigilance and Adverse Drug Reactions
Publication details
- Journal / source
- Reactions Weekly
- Volume
- 2091
- Issue
- 1
- Pages
- 51–51
- Publication date
- 3 January 2026
- Language
- EN